Alcorcón Foundation University Hospital

Information

cardiovascular diseases, neurodegenerative diseases, rare diseases

If you are the contact person for this centre and you wish to make any changes, please contact us.

SMC participants

President of the Spanish Society of Arteriosclerosis and physician in the Internal Medicine Unit of the Hospital Universitario Fundación Alcorcón.

Contents related to this centre
colchicina

In a study published in the journal Nature Medicine, a team of researchers from the National Center for Cardiovascular Research (CNIC) proposes a new cardiovascular risk factor to add to those already known. It is clonal hematopoiesis, a phenomenon caused by acquired mutations in blood stem cells. Furthermore, in a separate study published in the European Heart Journal, they suggest that the drug colchicine could serve to reduce its effects.